Today we have started shipping our 4 th Generation Athletic Smart insoles to the sports shoes manufacturers with whom we are in discussions. The 4th Generation Smart insole is the closest to commercial-ready product due to its significantly higher level of durability and resolution , as well as its improved communication and connectivity... more
We are a granted participant of the 10th International Conference on Advanced Technologies & Treatments for Diabetes(ATTD) , this week in Paris . The Company has been recognized for its contribution to the development of innovative solutions in the diabetes prevention and treatment fields and has won a grant for its participation at the... more
We are pleased to announce that we have entered into discussions with Tharawat of the Kingdom of Saudi Arabia in order to examine market potential collaboration in Prosthetic, Orthotic and Diabetic Foot Clinics.more
HCi Viocare announces the appointment of Brian Maguire as Director of its subsidiary HCi Viocare Clinics. Brian Maguire, BSc., MISPO, MBAPO, is the Senior Prosthetist of the company's first clinic operating as a centre of excellence in Glasgow. He is HCPC registered and a member of BAPO. He holds a BSc in Prosthetics and Orthotics from the... more
HCi Viocare is pleased to announce that it has entered into discussions with one of the major sport shoes manufacturers in the world, New Balance Athletics, Inc . HCi Viocare enters into discussions with New Balance Athletics, Inc. http://flexisense.hciviocare.com/sports-and-well-being/more
HCi Viocare Clinics is happy to support the PORT-ER charity’s event Patient Information Day –prosthetics and orthotics- 2016 , as a diamond sponsor . The event takes place in the Holiday Inn Glasgow , on the 3 rd of December, the International Day of Persons with Disabilities. PORT-ER charity’s vision is to bring better patient care for people... more
HCi Viocare has been recognized for its contribution to the development of innovative solutions in the diabetes prevention and treatment fields by being awarded a Startup Grant for the Technology Fair at the 10th International Conference on Advanced Technologies & Treatments for Diabetes(ATTD). The Conference will take place in Paris, France... more
HCi Viocare Technologies, has signed a licensing agreement with Carilex Medical Inc. a leading medical mattresses manufacturer with global presence. The two companies combined forces in setting a common goal to redefine the way in which nursing monitoring and care of bedridden patients takes place , incorporating the groundbreaking Flexisense™... more
We are proud to be short-listed for the 2016 start-up award of the IET Innovation Awards. Flexisense has, once more, been distinguished as a disruptive innovation which demonstrates a high value solution that fills up important gaps in healthcare and achieves early commercial traction. http://conferences.theiet.org/innovation/categories/start-up/... more
HCi Viocare Technologies has developed a new application for its revolutionary sensing technology Flexisense™, now for automotive tires . Flexisense™ applied to the automotive sector brings vehicle users the future of the ultimate driving experience. Flexisense™ applied to tires is able to monitor in real time tire deformation and actual traction... more
Glasgow is hosting the 44th EMBC, the world’s largest International Conference for biomedical engineering, in 2022 at the SECC. This significant development, which constitutes a deep recognition and high acceptance of the British-Scottish scientific community, has been secured by Professor Bill Sandham , HCi Viocare’s Director, Diabetes Technology... more
HCi Viocare Technologies is happy to annnounce its participation at the John Hancock Sports & Fitness Expo from April 15 at the Hynes Convention Center in Boston, MA, aiming to demonstrate its groundbreaking pressure and shear sensing technology FLEXISENSE in one of its most exciting implementation s , the Smart Sports Insole . The John... more
The sensor system of HCi Viocare is getting a name and logo! FLEXISENSE™ . The new name is inspired by the unique advantages of the technology, which demonstrates a high level of flexibility in terms of different uses, bendability, durability in different conditions, accessibility in respect to cost and adaptability in processes. Flexisense has... more
HCi Viocare announced its board of directors has agreed to source up to EUR 30 million in funding. Proceeds from the financing will be used for marketing its patent pending 'smart insole', the development of its other Smart Medical solutions, for general operating capital, as well as the expansion of its proposed chain of independent prosthetics... more
HCi Viocare today announced entering into discussions with various agents, private individuals and investment firms to raise additional capital for its 2016 and 2017 operations, as well as the expansion of its proposed chain of independent prosthetics and orthotics (P&O) and diabetic foot clinics. Sotirios Leontaritis, CEO and President of HCi... more

Pages